The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

clinomics.com

Founded Year

2011

Stage

IPO | IPO

Total Raised

$19.32M

Date of IPO

12/4/2020

Market Cap

130.00B

About Clinomics

Clinomics is a biotechnology company that specializes in offering a genome-based, early cancer diagnostic service through the technology of Multi-Omics analysis and simultaneous detection of CTC and cfDNA in the blood with its biomedical information processing abilities.

Clinomics Headquarter Location

50 Unist-Gil, Eonyang-eup Ulju-gun

Ulsan, 44919,

South Korea

+82 070-8286-6966

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Clinomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Clinomics is included in 5 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

H

Health IT

7,900 items

Clinomics Patents

Clinomics has filed 3 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Continuum mechanics
  • Epidemiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/22/2017

3/22/2022

Fluid dynamics, Microfluidics, Fluid mechanics, Continuum mechanics, Valves

Grant

Application Date

12/22/2017

Grant Date

3/22/2022

Title

Related Topics

Fluid dynamics, Microfluidics, Fluid mechanics, Continuum mechanics, Valves

Status

Grant

Latest Clinomics News

FDA Grants EUAs for Coronavirus Tests from Clinomics, Princeton BioMeditech, UPenn, Inno Diagnostics

Feb 8, 2021

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorizations for a PCR-based SARS-CoV-2 test developed by Clinomics and a combination SARS-CoV-2/influenza point-of-care antigen test from Princeton BioMeditech. In addition, last month it granted EUAs for PCR-based SARS-CoV-2 tests developed by the University of Pennsylvania and Inno Diagnostics Reference Laboratory. To read the full story.... Email:

Clinomics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Clinomics Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.